EFFICACY AND SAFETY OF INHALED NITRIC OXIDE USE IN PATIENTS WITH PULMONARY HYPERTENSION AND CHRONIC HEART FAILURE III-IV FUNCTIONAL CLASS, SURVIVED LEFT VENTRICULAR MYOCARDIAL INFARCTION: RESULTS OF NON-RANDOMIZED COMAPARIVE STUDY

EFFICACY AND SAFETY OF INHALED NITRIC OXIDE USE IN PATIENTS WITH PULMONARY HYPERTENSION AND CHRONIC HEART FAILURE III-IV FUNCTIONAL CLASS, SURVIVED LEFT VENTRICULAR MYOCARDIAL INFARCTION: RESULTS OF NON-RANDOMIZED COMAPARIVE STUDY

Show other versions (1)

<p><strong>Aim</strong> – assessment of the influence of inhaled nitric oxide (NO) on the course of pulmonary hypertension (PH) in patients with chronic heart<br />failure (CHF) III–IV functional class (FC), myocardial infarction (MI).</p><p><br /><strong...

Full description

Bibliographic Details
Main Authors:	P. N. Pavlenko, O. M. Drapkina, I. E. Sergeev, V. T. Ivashkin
Format:	Article
Language:	Russian
Published:	ABV-press 2014-07-01
Series:	Klinicist
Subjects:	pulmonary hypertension inhaled nitric oxide heart failure pulmonary hypertension treatment
Online Access:	http://klinitsist.abvpress.ru/index.php/Klin/article/view/99

Similar Items

EFFICACY AND SAFETY OF INHALED NITRIC OXIDE USE IN PATIENTS WITH PULMONARY HYPERTENSION AND CHRONIC HEART FAILURE III-IV FUNCTIONAL CLASS, SURVIVED LEFT VENTRICULAR MYOCARDIAL INFARCTION: RESULTS OF NON-RANDOMIZED COMAPARIVE STUDY
by: P. N. Pavlenko, et al.
Published: (2014-07-01)

The Impact of Combined Oral Sildenafil and Inhaled Nitric Oxide for Treating Persistent Pulmonary Hypertension of the Newborn: A Single Center Experience
by: Hayriye Gozde Kanmaz, et al.
Published: (2017-08-01)

Safety of inhaled nitric oxide withdrawal in severe chronic pulmonary hypertension
by: Gregorio Miguel Pérez‐Peñate, et al.
Published: (2024-01-01)

Inhaled Nitric Oxide at Birth Reduces Pulmonary Vascular Resistance and Improves Oxygenation in Preterm Lambs
by: Satyan Lakshminrusimha, et al.
Published: (2021-05-01)

Inhaled nitric oxide: are expectations justified?
by: I. A. Kozlov
Published: (2024-12-01)

The acute effect of inhaled nitric oxide on the exercise capacity of patients with advanced interstitial lung disease: a randomized controlled trial
by: Lev Freidkin, et al.
Published: (2024-05-01)

Correlation of ABO blood groups with treatment response and efficacy in infants with persistent pulmonary hypertension of the newborn treated with inhaled nitric oxide
by: Yi Guan, et al.
Published: (2023-04-01)

Inhaled nitric oxide: can it serve as a savior for COVID-19 and related respiratory and cardiovascular diseases?
by: Yifan Zhao, et al.
Published: (2023-10-01)

Evaluation of the effect of nitric oxide inhalation in the patients with chronic thromboembolic pulmonary hypertension or pulmonary disease during balloon pulmonary angioplasty
by: Shota Saito, et al.
Published: (2022-01-01)

INHALED NITRIC OXIDE: CLINICAL EFFECTS AND INFLUENCE ON THE PROFILE OF INFLAMMATORY MARKERS IN PATIENTS WITH IDIOPATHIC PULMONARY HYPERTENSION
by: T. V. Martynyuk, et al.
Published: (2015-12-01)

Inhaled nitric oxide testing in predicting prognosis in pulmonary hypertension due to left‐sided heart diseases
by: Taijyu Satoh, et al.
Published: (2023-12-01)

COMPARISON OF HEMODYNAMIC EFFECTS OF INHALATORY ILOPROST AND NITRIC OXIDE IN PATIENTS WITH SEVERE LEFT VENTRICLE DYSFUNCTION
by: A. E. Bautin, et al.
Published: (2017-12-01)

Role of prostanoids, nitric oxide and endothelin pathways in pulmonary hypertension due to COPD
by: Abdullah A. Alqarni, et al.
Published: (2023-10-01)

The early use of inhaled nitric oxide in premature infants requiring respiratory support
by: Ahmed Osman
Published: (2023-12-01)

Inhaled iloprost is an effective alternative therapy for persistent pulmonary hypertension in newborns
by: Şükran Yıldırım
Published: (2023-07-01)

PULMONARY HYPERTENSION: DIFFICULT CASE IN CLINICAL PRACTICE
by: D. V. Madeeva, et al.
Published: (2014-07-01)

Comparison of intravenous sildenafil with inhaled nitric oxide for acute vasodilator testing in pulmonary arterial hypertension
by: Shine Kumar, et al.
Published: (2022-10-01)

Acute myocardial infarction following inhaled treprostinil initiation
by: Bilal Alqam, et al.
Published: (2025-01-01)

Resolution of Severe Portopulmonary Hypertension With Inhaled Treprostinil and Liver Transplantation
by: Alex J. Chang, MD, et al.
Published: (2024-03-01)

Study of the hemodynamic effect of inhaled milrinone versus inhaled nitroglycerin on mechanically ventilated patients with pulmonary hypertension after mitral valve replacement surgeries
by: Ahmed K. Abdel Ghany Hassan, et al.
Published: (2022-01-01)

Inhaled NO at a crossroads in cardiac surgery: current need to improve mechanistic understanding, clinical trial design and scientific evidence
by: Stefan Muenster, et al.
Published: (2024-04-01)

Nitric oxide unravels the enigmatic function of the paranasal sinuses: a review of literature
by: Remon Bazak, et al.
Published: (2020-08-01)

Acute Respiratory Distress Syndrome (ARDS) After Nitric Acid Inhalation
by: Gülay Kır, et al.
Published: (2014-12-01)

A case of the effective inhalation of nitric oxide therapy for caused severe pulmonary hypertension with protamine neutralization of systemic heparinization during totally endoscopic minimally invasive cardiac surgery
by: Takeichi Tomohisa, et al.
Published: (2024-09-01)

Efficacy of inhaled iloprost in children with pulmonary hypertension after pediatric cardiac surgery: a case series
by: Ergin Arslanoğlu, et al.
Published: (2024-04-01)

Lack of Association between Inhaled Corticosteroid Use Based on the Exhaled Nitric Oxide and Acute Exacerbation of Chronic Obstructive Pulmonary Disease
by: Bo-Guen Kim, et al.
Published: (2024-07-01)

Evaluation of patients with severe pulmonary hypertension and a range of comorbidities prescribed inhaled treprostinil
by: Aparna C. Swaminathan, et al.
Published: (2024-11-01)

Hydrogen Inhalation Reduces Lung Inflammation and Blood Pressure in the Experimental Model of Pulmonary Hypertension in Rats
by: Tatyana Kuropatkina, et al.
Published: (2023-11-01)

Management of neonatal pulmonary hypertension-a survey of neonatal intensive care units in India
by: Pari Singh, et al.
Published: (2023-03-01)

Novel left ventricular mechanical index in pulmonary arterial hypertension
by: Kenzo Ichimura, et al.
Published: (2023-04-01)

Pulmonary Hypertension Is Associated With Systemic Arterial Hypertension Among Patients With Normal Left Ventricular Diastolic Function
by: Edward Itelman, et al.
Published: (2021-12-01)

Pulmonary Endarterectomy in Latvia: A National Experience
by: Matiss Sablinskis, et al.
Published: (2019-01-01)

EFFECTIVENESS OF ILOPROST IN PATIENTS WITH PULMONARY HYPERTENSION FC III - IV BASED ON VORONEZH REGION REGISTRY DATA
by: O. M. Korolkova, et al.
Published: (2019-06-01)

Ciddi Pulmoner Hipertansiyonlu Komplet Atriyoventriküler Kanal Defekti Onarımından Sonra Kombine İnhale Nitrik Oksit ve Oral Sildenafil Kullanılması: Vaka Sunumu ve Literature Taraması
by: Sinan Arsan, et al.
Published: (2018-01-01)

Prognostic value of pulmonary hypertension with a nomogram in acute myocardial infarction patients with reduced left ventricular function
by: Qian Liu, et al.
Published: (2024-04-01)

Severe bronchospasm and acute respiratory failure associated with inhaled prostacyclin therapy
by: Donna Steinbacher, et al.
Published: (2024-04-01)

Pulmonary hypertension due to left upper lobe partial anomalous pulmonary venous return
by: Semi Öztürk, et al.
Published: (2016-12-01)

Novel use of riociguat in infants with severe pulmonary arterial hypertension unable to wean from inhaled nitric oxide
by: L. T. Domingo, et al.
Published: (2022-12-01)

Relation between endothelial nitric oxide synthase genetic polymorphisms and pulmonary arterial hypertension in newborns with congenital heart disease
by: Qing-Fan Lin, et al.
Published: (2022-08-01)

Human Pulmonary Artery Endothelial Cells Increased Glycolysis and Decreased Nitric Oxide Synthase O-GlcNAcylation in Pulmonary Arterial Hypertension
by: Sarah E. Basehore, et al.
Published: (2024-02-01)